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Summary
Background:  West  syndrome  is  an  age-dependent  epileptic  encephalopathy.  Autonomic  changes
are increasingly  being  recognized  in  patients  with  epilepsy:  cardiac  autonomic  function  is
mediated  by  sympathetic  and  parasympathetic  efferent  activity  to  the  heart  and  can  provide
information  on  the  functional  state  of  the  autonomic  nervous  system.  The  goal  of  the  study  is
to evaluate  the  effect  of  an  early  epileptic  encephalopathy  on  the  autonomic  nervous  system
by measuring  heart  rate  variability.
Methods:  Cardiac  autonomic  function  was  evaluated  in  13  patients  with  West  syndrome  by
measuring heart  rate  variability  during  5  min  epochs  of  ECG  in  wake,  stage  2  and  slow  wave
sleep. In  5  patients  who  developed  subsequently  another  type  of  epilepsy,  a  second  evaluation
was performed  after  3  years  of  follow-up.
Results:  Results  showed  a  lower  heart  rate  in  stage  2  sleep  in  patients  with  West  syndrome.
Spectral  components  did  not  show  significant  differences  compared  to  age  matched  controls  at
the moment  of  presentation.  After  follow-up  of  3  years  we  were  able  to  demonstrate  higher
low frequency  (LF),  lower  high  frequency  (HF)  and  a  higher  LF/HF  ratio  during  slow  wave  sleep.
Conclusion:  This  study  shows  a  lower  heart  rate  in  patients  presenting  with  West  syndrome,
already at  the  onset  of  the  syndrome  and  before  ACTH  treatment.  The  epileptic  encephalopathy
is not  sufficient  to  alter  spectral  components  of  heart  rate  at  the  moment  of  presentation.
However,  already  after  3  years  of  epilepsy,  chronic  autonomic  changes  appear.
r  B.V© 2012  Published  by  ElseviePlease  cite  this  article  in  press  as:  Jansen,  K.,  et  al.,  Cardiac
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ntroduction
est  syndrome  is  an  age-dependent  epileptic  syndrome
haracterized  by  epileptic  spasms,  hypsarrhythmia  on  EEG
nd  arrest  or  regression  in  psychomotor  development.  The
pileptic  spasms  resolve  over  time  but  they  are  often autonomic  dysfunction  in  West  syndrome.  Epilepsy  Res.
eplaced  by  other  types  of  refractory  seizures  (Commission
n  Pediatric  Epilepsy  of  the  International  League  Against
pilepsy,  1992). Autonomic  changes  are  increasingly  being
ecognized  in  patients  with  epilepsy  (Baumgartner  et  al.,
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001). One  way  to  look  at  the  autonomic  system  is  to  study
eart  rate  variability.  Heart  rate  variability  is  defined  as
he  fluctuation  in  length  in  consecutive  RR  intervals.  This
ariability  is  mediated  by  sympathetic  and  parasympathetic
fferent  activity  to  the  heart  and  can  show  information  on
he  functional  state  of  the  autonomic  nervous  system.  The
agal  influences  on  the  heart  are  most  pronounced  during
leep  and  reach  a  maximum  in  synchronized  or  slow  wave
leep.
Acute  changes  of  cardiac  function  at  the  time  of  a  seizure
n  patients  with  epilepsy  is  caused  by  involvement  of  the
entral  autonomic  control  centers  in  seizure  activity.  On  the
ther  hand,  patients  with  longlasting  or  refractory  epilepsy
re  prone  to  chronic  dysfunction  of  autonomic  cardiac  con-
rol  (Chroni  et  al.,  2008;  Harnod  et  al.,  2008;  Ferri  et  al.,
002).
The  goal  of  this  study  was  to  investigate  the  immediate
nd  long-term  effect  of  an  early  epileptic  encephalopa-
hy  on  the  autonomic  nervous  system.  We  evaluate  heart
ate  variability  at  the  moment  of  diagnosis  to  investigate
he  short-term  effect  of  the  epileptic  encephalopathy  on
utonomic  function.  Furthermore,  we  performed  a  second
valuation  after  3  years  of  epilepsy  to  monitor  the  chronic
ffects  of  epilepsy  on  the  autonomic  nervous  system.
ethods
onsecutive  patients  who  presented  with  infantile  spasms
nd  hypsarrhytmia  on  EEG  at  the  epilepsy  clinic  of  UZ  Leu-
en  between  2003  and  2010  were  included.  All  patients
ere  included  and  monitored  before  treatment  with  ACTH
t  the  moment  of  their  referral  and  first  EEG.  Control
ubjects  were  referred  to  the  epilepsy  clinic  with  sus-
icion  of  epilepsy  but  were  found  to  have  benign  sleep
yoclonus  and  had  normal  EEG  findings.  All  EEGs  were
eviewed  by  2  independent  EEG  specialists.  The  control
ubjects  were  age  and  sex  matched  to  take  into  account
ge-dependent  differences.  EEG  recordings  were  obtained
sing  the  10—20  International  System  of  Electrode  Place-
ent.  Sampling  rate  was  250  Hz.  5  min  epochs  of  ECG  were
xtracted  randomly  during  wake,  stage  2  sleep  and  slow
ave  sleep  of  the  first  sleep  cycle.  All  EEGs  had  continuous
nterictal  discharges  but  no  seizures.  In  patients  who  subse-
uently  developed  another  type  of  epilepsy,  5  min  epochs  of
CG  were  extracted  again  during  the  three  time  points  after
inimal  3  years  of  follow-up.  Again  age-matched  controls
ere  used  for  comparison  of  the  follow-up  cases.  Wake  and
leep  stages  were  determined  by  the  investigator  by  visual
nalysis  of  the  EEG  and  spectral  analysis  (OSG,  Belgium).
R  intervals  were  calculated  after  automatic  QRS-complex
etection.  Finally,  all  RR  interval  time  series  were  checked
anually.
Heart  rate  variability  can  be  used  as  a  tool  to  show  infor-
ation  on  the  functional  state  of  the  autonomic  nervous
ystem.  Frequency  domain  analysis  was  performed  using  a
on-parametric  method  of  fast  Fourier  transformation.  Bor-
ers  of  spectral  components  were  defined  according  to  age.
ime  and  frequency  domain  analysis  of  heart  rate  variabilityPlease  cite  this  article  in  press  as:  Jansen,  K.,  et  al.,  Cardiac
(2012),  http://dx.doi.org/10.1016/j.eplepsyres.2012.05.010
as  done  according  to  the  standards  of  the  Task  Force  of  the
uropean  Society  of  Cardiology  (Task  Force  of  The  European
ociety  of  Cardiology  and  The  North  American  Society  of
acing  and  Electrophysiology,  1996). Spectral  analysis  of
o
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eart  rate  can  provide  more  information  on  the  sympathetic
nd  parasympathetic  contribution  to  autonomic  outflow  to
he  heart.  The  high  frequency  (HF)  components  are  related
o  parasympathetic  activity,  whereas  the  low  frequency  (LF)
eflects  sympathetic  cardiac  function.
Spectral  components  in  the  first  cohort  were  defined  as
.04—0.15  Hz  for  LF  and  0.30—1.30  Hz  for  the  HF  component,
overing  the  breathing  frequencies  of  all  the  young  sub-
ects.  In  the  second  cohort,  spectral  components  between
.04  and  0.15  Hz  were  defined  as  LF,  those  between  0.15  and
.40  Hz  were  defined  as  HF.  Normalized  units  were  used  to
ompare  spectra  with  different  total  power.  LFnu  =  LF/(total
ower  −VLF)  ×  100,  HFnu  =  HF/(total  power  −  VLF)  ×  100.
he  LF/HF  ratio  was  used  to  quantify  the  sympathovagal
alance  as  an  indicator  of  autonomic  modulation.  Differ-
nces  between  epileptic  patients  and  the  control  group  were
btained  via  the  Mann—Whitney  U  test.  P  <  0.05  was  consid-
red  statistically  significant.
esults
3  patients  with  infantile  spasms  at  presentation  were
ncluded  and  an  equal  number  of  age  matched  controls.  The
ean  age  of  onset  was  7.3  months  (range  4—10  months).
Ten  patients  developed  subsequently  another  type  of
pilepsy,  9  had  generalized  and  1  partial  epilepsy,  8  of  them
ere  refractory  cases.  All  patients  had  mild  to  severe  men-
al  retardation.  5  of  these  subjects  had  a follow-up  period
f  minimal  3  years.  Other  patient  characteristics  and  treat-
ent  before  the  encephalographic  evaluation  is  shown  in
able  1.
omparison  between  West  syndrome  patients  and
ontrols  at  the  onset  of  epilepsy
esults  in  time  and  frequency  domain  measurements  were
ompared  between  West  syndrome  and  controls  using  the
rst  set  of  data.
In  time  domain  the  mean  RR  interval  was  significantly
igher  in  patients  versus  controls  during  stage  2  sleep
535.9  ±  47.5  ms  versus  491.4  ±  51.4  ms;  p  =  0.03).  The  dif-
erence  was  also  observed  during  wake  (450.5  ±  46.6  ms
ersus  411.5  ±  41.2  ms;  p  =  0.12)  and  slow  wave  sleep
518.5  ±  56.6  ms  versus  482.7  ±  39.4  ms;  p  =  0.09)  but  not
tatistically  significant.  Other  time  domain  analyses  showed
o  significant  differences.  In  the  frequency  domain,  there
ere  no  statistically  significant  differences  in  power  spectra
f  patients  versus  controls  in  the  different  sleep  stages.
omparison  between  West  syndrome  patients  who
ubsequently  developed  epilepsy  and  controls
esults  in  time  and  frequency  domain  measurements  were
ompared  between  former  West  syndrome  patients  after  at
east  3  years  of  follow-up  and  controls,  using  the  second  set
f  data. autonomic  dysfunction  in  West  syndrome.  Epilepsy  Res.
In  time  domain  there  were  no  significant  findings.  On  the
ther  hand,  in  frequency  domain  there  is  an  important  dif-
erence  in  LF  (0.363  ±  0.154  versus  0.160  ±  0.109;  p  =  0.03)
nd  HF  (0.494  ±  0.157  versus  0.737  ±  0.153;  p  =  0.01)  power
Please
 cite
 this
 article
 in
 press
 as:
 Jansen,
 K.,
 et
 al.,
 Cardiac
 autonom
ic
 dysfunction
 in
 W
est
 syndrom
e.
 Epilepsy
 Res.
(2012),
 http://dx.doi.org/10.1016/j.eplepsyres.2012.05.010
A
RTICLE IN PRESS
+M
odel
EPIRES-4776;
 
N
o.
 of
 Pages
 6
Cardiac
 autonom
ic
 dysfunction
 in
 W
est
 syndrom
e
 
3
Table  1  Patient  characteristics.
Case  no. Age  at
onset
(months)
Sex
(male/female)
Treatment Etiology Subsequent
epilepsy
Treatment Age  at  first  EEG
evaluation
(months)
Age  at  second
EEG  evaluation
(years)
1 6 M Vigabatrin,
Sodiumvalproate
Cryptogenic Yes,
generalized
Sodiumvalproate,
clobazam,
sulthiame
8 4.5
2 5 F Sodiumvalproate Cryptogenic Yes,
generalized
Sodiumvalproate 6.5  7.5
3 8 M Vigabatrin,
sodiumvalproate
Symptomatic:
trisomy 21
Yes,
generalized
Topiramate 9 6.5
4 9 M Sodiumvalproate Cryptogenic No — 9 —
5 7 M Vigabatrin,
sodiumvalproate
Symptomatic:  ACM
infarct
Yes,
generalizee
Sodiumvalproate,
topiramate,
clobazam
9 —
6 10 M  Sodiumvalproate  Symptomatic  Yes,
generalized
Sodiumvalproate,
vigabatrine,
clonazepam
10  —
7 10  M  Vigabatrin,
sodiumvalproate
Symptomatic  No  —  10  —
8 10  M  Vigabatrin,
carbamazepine
Symptomatic:
tuberous  sclerosis
Yes,  partial  Sodiumvalproate,
topiramate,
clobazam
11  6
9 6  F  Vigabatrin  Symptomatic:
tuberous  sclerosis
Yes,
generalized
Sodiumvalproate  6  3
10 5  M  Sodiumvalproate,
topiramate
Symptomatic:
tuberous  sclerosis
Yes,
generalized
Sodiumvalproate,
topiramate
10  —
11 6 M Sodiumvalproate  Cryptogenic  No  —  7  —
12 4 F  Vigabatrin  Symptomatic:
trisomy  21
Yes,
generalized
Sodiumvalproate  4  —
13 9 M None  Symptomatic:
trisomy  21
Yes,
generalized
Sodiumvalproate,
levetiracetam
10  —
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Figure  1  LFnu,  HFnu  and  LF/HF  ratio  in  patients  and  controls  after  3  years  of  follow-up.  Figure  shows  the  higher  contribution
of LF  and  lower  contribution  of  HF  components  to  the  spectral  power  of  patients  with  West  compared  to  controls.  This  leads  to  a
h
i
t
0
oigher LF/HF  ratio.Please  cite  this  article  in  press  as:  Jansen,  K.,  et  al.,  Cardiac
(2012),  http://dx.doi.org/10.1016/j.eplepsyres.2012.05.010
n  patients  with  epilepsy  during  slow  wave  sleep  compared
o  controls.  This  is  also  observed  in  the  LF/HF  ratio  (patients
.997  versus  controls  0.247;  p  =  0.03).  These  findings  are  not
bserved  in  wake  or  stage  2  sleep  (see  Fig.  1).
D
L
w autonomic  dysfunction  in  West  syndrome.  Epilepsy  Res.
iscussion
ooking  at  short-term  effects  in  our  patient  population,  we
ere  able  to  demonstrate  a  lower  heart  rate  in  patients
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Cardiac  autonomic  dysfunction  in  West  syndrome  
with  West  syndrome  already  before  ACTH  treatment,  in  con-
trast  to  the  findings  of  Hattori  et  al.  (2007). The  decrease  in
heart  rate  can  be  a  sign  of  parasympathetic  predominance
on  the  autonomic  outflow  to  the  heart.  The  finding  is  most
significant  during  stage  2  sleep,  where  vagal  components
are  physiologically  less  pronounced.  During  slow  wave  sleep
vagal  components  are  physiologically  most  prominent.  Our
findings  suggest  that  there  is  already  a  difference  in  heart
rate  regulation  in  patients  presenting  with  West  syndrome.
One  of  the  pathophysiological  hypotheses  in  West  syndrome
is  the  activation  of  a  stress  response  and  release  of  corti-
cotropin  releasing  hormone  (CRH).  An  early  insult  on  the
brain  e.g.  cerebral  infarction  provokes  a  stress  response.
This  mediates  an  excessive  release  of  CRH.  In  the  develop-
ing  brain,  this  excessive  release  can  cause  epileptic  spasms
and  neuronal  cell  death,  most  important  in  amygdalae  and
hippocampus  (Rho,  2004;  Brunson  et  al.,  2001). A  high  level
of  CRH  will  cause  a  rise  in  cortisol  through  production  of
ACTH.  The  autonomic  vagal  response  could  be  a  counter-
balance  for  the  cortisol-induced  effects  on  bloodpressure
and  cardiac  function.  This  is  comparable  with  the  findings  in
patients  with  Cushing,  who  also  have  a  relatively  increased
parasympathetic  activity  and  lower  heart  rate  (Fallo  et  al.,
2009).  Treatment  with  ACTH  could  make  these  findings  even
more  pronounced,  as  observed  by  Hattori.
Looking  at  the  follow-up  data,  we  were  able  to  demon-
strate  higher  LF,  lower  HF  and  a  higher  LF/HF  ratio  during
slow  wave  sleep  in  patients  who  developed  epilepsy  after
West  syndrome  compared  to  controls.  These  findings  are
already  present  after  3  years  of  epilepsy.  In  normal  sleep,
vagal  components  are  always  most  pronounced  during  syn-
chronized  or  slow  wave  sleep.  This  normal  phenomenon  is  no
longer  visible  in  our  cohort  of  patients  with  former  West  syn-
drome.  Vagal  reduction  in  patients  with  longlasting  epilepsy
has  been  previously  observed  in  adults  as  well  as  in  chil-
dren  (Tomson  et  al.,  1998;  Evrengül  et  al.,  2005;  Jansen  and
Lagae,  2010). The  explanation  of  this  phenomenon  is  still
uncertain.  A  possible  mechanism  is  that  disruption  of  normal
autonomic  function  is  due  to  chronic  epileptic  activity.  In  a
study  by  Sathyaprabha  et  al.  (2006), the  autonomic  changes
were  more  severe,  the  longer  the  duration  of  epilepsy  was.
In  this  study  patients  with  longer  duration  of  epilepsy  (23.2
years)  had  more  severe  dysfunction  than  patients  with  rel-
atively  shorter  duration  (17.5  years)  of  epilepsy.  Therefore,
it  is  not  impossible  that  chronic  dysautonomia  can  already
be  present  after  a  relatively  short  phase  of  severe  epileptic
encephalopathy.
The  clinical  relevance  of  these  changes  in  patients  with
epilepsy  remain  an  open  question.  Reduced  heart  rate  vari-
ability  is  a  marker  of  dysfunction  of  the  autonomic  nervous
system  and  can  be  considered  a  risk  factor  in  chronic  disease
e.g.  myocardial  infarction  (Buccelletti  et  al.,  2009). Various
diseases  including  epilepsy  are  now  known  to  be  accom-
panied  by  a  loss  of  autonomic  functionality  and  reduced
HRV  (Chroni  et  al.,  2008). One  of  the  possible  mechanisms
underlying  sudden  unexplained  death  (SUDEP)  are  seizure
related  cardiac  arrhythmias  with  tachyarrhythmias  leading
to  ventricular  fibrillation  and  bradycardia  and  ictal  asystolePlease  cite  this  article  in  press  as:  Jansen,  K.,  et  al.,  Cardiac
(2012),  http://dx.doi.org/10.1016/j.eplepsyres.2012.05.010
(Tomson  et  al.,  2008).
We  did  consider  the  possible  effect  of  confounding
factors  e.g.  the  etiology  of  the  West  syndrome  and  the  dif-
ference  between  cryptogenic  and  symptomatic  cases,  the
F PRESS
5
umber  of  seizures  or  influence  of  medication,  but  we  were
nable  to  investigate  this  further  due  to  sample  size  con-
traints.  However  the  observed  results  are  so  consistent  that
e  believe  that  these  factors  can  only  be  responsible  for
nsignificant  differences.
Although  our  results  are  consistent,  we  need  more  studies
o  show  how  the  epileptic  encephalopathy  change  the  ANS
n  detail.
In  conclusion,  our  results  show  that  there  is  a  lower
eart  rate  in  patients  with  West  syndrome,  already  at  the
nset  of  the  syndrome,  even  before  treatment  with  ACTH.
he  epileptic  activity  at  onset  itself  is  not  sufficient  to
lter  spectral  components  of  heart  rate  on  the  short  term.
owever,  after  follow-up  of  3  years  of  epilepsy,  chronic  auto-
omic  changes  appear.
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